Drug treatment utilization before, during and after pregnancy
This study retrospectively explored drug treatment utilization before, during and after pregnancy for all identified substance-using women delivering at a county hospital over a 4-year period (n = 431). Drug treatment data were linked to hospital data to analyse treatment utilization. Fifty-three pe...
Gespeichert in:
| Veröffentlicht in: | Journal of substance use 2007-01, Vol.12 (1), p.27-38 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 38 |
|---|---|
| container_issue | 1 |
| container_start_page | 27 |
| container_title | Journal of substance use |
| container_volume | 12 |
| creator | Wolfe, Ellen L. Guydish, Joseph R. Santos, Ann Delucchi, Kevin L. Gleghorn, Alice |
| description | This study retrospectively explored drug treatment utilization before, during and after pregnancy for all identified substance-using women delivering at a county hospital over a 4-year period (n = 431). Drug treatment data were linked to hospital data to analyse treatment utilization. Fifty-three per cent received treatment the year before, during, or within the year after delivery, with a significantly higher proportion receiving treatment during and after pregnancy. There were significant increases in methadone and residential treatment services during pregnancy. Women spent significantly more time in treatment after delivery compared with before or during pregnancy. However, 47% of these women did not receive drug treatment. These findings support current literature suggesting that pregnancy presents an opportunity to engage women in treatment. However, there is a need to decrease the institutional, legal, and funding barriers that exist between health care and drug treatment providers. Utilizing available data to track perinatal substance use and treatment utilization are important to plan for adequate availability of treatment services for this population. |
| doi_str_mv | 10.1080/14659890600823826 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_14659890600823826</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>57219156</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4506-31b0b576d93a6338beb344f53c6d477449f4253d09f28091fe03a5e30b91e0353</originalsourceid><addsrcrecordid>eNp9kUuLFDEUhYMozjj6A9xIrcTFtCa5SaqCDxjGJwy40XVIVSXdGaqS9ialtL_eND0ODkKvciDfOdx7LiFPGX3JaEdfMaGk7jRVlHYcOq7ukVMmWrnSWvD7e62q7jQ7IY9yvqaUMyHFQ3LCecs05-KUvH2Py7op6GyZXSzNUsIUftsSUmx65xO682ZcMMR1Y-PYWF8cNlt062jjsHtMHng7Zffk5j0j3z9--Hb5eXX19dOXy4ur1SAkVStgPe1lq0YNVgF0vetBCC9hUKNoWyG0F1zCSLXnHdXMOwpWOqC9ZlVKOCPvDrnbpZ_dONRJ0U5mi2G2uDPJBnP3J4aNWaefBqBtgUMNeH4TgOnH4nIxc8iDmyYbXVqykS1nmklVwRdHQdaBlHLffkXZAR0w5YzO387DqNkT5r_7VM-zfxe5dfw9SAXeHIAQa_mz_ZVwGk2xuymhx9p5yAaO5b--Y984O5XNYNGZ67RgrEc6Mt0fcOuvnQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835551080</pqid></control><display><type>article</type><title>Drug treatment utilization before, during and after pregnancy</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Taylor & Francis</source><source>Taylor & Francis Medical Library - CRKN</source><creator>Wolfe, Ellen L. ; Guydish, Joseph R. ; Santos, Ann ; Delucchi, Kevin L. ; Gleghorn, Alice</creator><creatorcontrib>Wolfe, Ellen L. ; Guydish, Joseph R. ; Santos, Ann ; Delucchi, Kevin L. ; Gleghorn, Alice</creatorcontrib><description>This study retrospectively explored drug treatment utilization before, during and after pregnancy for all identified substance-using women delivering at a county hospital over a 4-year period (n = 431). Drug treatment data were linked to hospital data to analyse treatment utilization. Fifty-three per cent received treatment the year before, during, or within the year after delivery, with a significantly higher proportion receiving treatment during and after pregnancy. There were significant increases in methadone and residential treatment services during pregnancy. Women spent significantly more time in treatment after delivery compared with before or during pregnancy. However, 47% of these women did not receive drug treatment. These findings support current literature suggesting that pregnancy presents an opportunity to engage women in treatment. However, there is a need to decrease the institutional, legal, and funding barriers that exist between health care and drug treatment providers. Utilizing available data to track perinatal substance use and treatment utilization are important to plan for adequate availability of treatment services for this population.</description><identifier>ISSN: 1465-9891</identifier><identifier>EISSN: 1475-9942</identifier><identifier>DOI: 10.1080/14659890600823826</identifier><identifier>PMID: 22719224</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Drug replacement therapy ; drug treatment ; Perinatal period ; Pregnancy ; Residential treatment ; Substance abuse ; Substance use ; Women</subject><ispartof>Journal of substance use, 2007-01, Vol.12 (1), p.27-38</ispartof><rights>2007 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2007</rights><rights>2007 Informa UK Ltd. 2007</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4506-31b0b576d93a6338beb344f53c6d477449f4253d09f28091fe03a5e30b91e0353</citedby><cites>FETCH-LOGICAL-c4506-31b0b576d93a6338beb344f53c6d477449f4253d09f28091fe03a5e30b91e0353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/14659890600823826$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/14659890600823826$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>230,314,776,780,881,27903,27904,30979,59623,59729,60412,60518,61197,61232,61378,61413</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22719224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wolfe, Ellen L.</creatorcontrib><creatorcontrib>Guydish, Joseph R.</creatorcontrib><creatorcontrib>Santos, Ann</creatorcontrib><creatorcontrib>Delucchi, Kevin L.</creatorcontrib><creatorcontrib>Gleghorn, Alice</creatorcontrib><title>Drug treatment utilization before, during and after pregnancy</title><title>Journal of substance use</title><addtitle>J Subst Use</addtitle><description>This study retrospectively explored drug treatment utilization before, during and after pregnancy for all identified substance-using women delivering at a county hospital over a 4-year period (n = 431). Drug treatment data were linked to hospital data to analyse treatment utilization. Fifty-three per cent received treatment the year before, during, or within the year after delivery, with a significantly higher proportion receiving treatment during and after pregnancy. There were significant increases in methadone and residential treatment services during pregnancy. Women spent significantly more time in treatment after delivery compared with before or during pregnancy. However, 47% of these women did not receive drug treatment. These findings support current literature suggesting that pregnancy presents an opportunity to engage women in treatment. However, there is a need to decrease the institutional, legal, and funding barriers that exist between health care and drug treatment providers. Utilizing available data to track perinatal substance use and treatment utilization are important to plan for adequate availability of treatment services for this population.</description><subject>Drug replacement therapy</subject><subject>drug treatment</subject><subject>Perinatal period</subject><subject>Pregnancy</subject><subject>Residential treatment</subject><subject>Substance abuse</subject><subject>Substance use</subject><subject>Women</subject><issn>1465-9891</issn><issn>1475-9942</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNp9kUuLFDEUhYMozjj6A9xIrcTFtCa5SaqCDxjGJwy40XVIVSXdGaqS9ialtL_eND0ODkKvciDfOdx7LiFPGX3JaEdfMaGk7jRVlHYcOq7ukVMmWrnSWvD7e62q7jQ7IY9yvqaUMyHFQ3LCecs05-KUvH2Py7op6GyZXSzNUsIUftsSUmx65xO682ZcMMR1Y-PYWF8cNlt062jjsHtMHng7Zffk5j0j3z9--Hb5eXX19dOXy4ur1SAkVStgPe1lq0YNVgF0vetBCC9hUKNoWyG0F1zCSLXnHdXMOwpWOqC9ZlVKOCPvDrnbpZ_dONRJ0U5mi2G2uDPJBnP3J4aNWaefBqBtgUMNeH4TgOnH4nIxc8iDmyYbXVqykS1nmklVwRdHQdaBlHLffkXZAR0w5YzO387DqNkT5r_7VM-zfxe5dfw9SAXeHIAQa_mz_ZVwGk2xuymhx9p5yAaO5b--Y984O5XNYNGZ67RgrEc6Mt0fcOuvnQ</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Wolfe, Ellen L.</creator><creator>Guydish, Joseph R.</creator><creator>Santos, Ann</creator><creator>Delucchi, Kevin L.</creator><creator>Gleghorn, Alice</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QJ</scope><scope>5PM</scope></search><sort><creationdate>20070101</creationdate><title>Drug treatment utilization before, during and after pregnancy</title><author>Wolfe, Ellen L. ; Guydish, Joseph R. ; Santos, Ann ; Delucchi, Kevin L. ; Gleghorn, Alice</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4506-31b0b576d93a6338beb344f53c6d477449f4253d09f28091fe03a5e30b91e0353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Drug replacement therapy</topic><topic>drug treatment</topic><topic>Perinatal period</topic><topic>Pregnancy</topic><topic>Residential treatment</topic><topic>Substance abuse</topic><topic>Substance use</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wolfe, Ellen L.</creatorcontrib><creatorcontrib>Guydish, Joseph R.</creatorcontrib><creatorcontrib>Santos, Ann</creatorcontrib><creatorcontrib>Delucchi, Kevin L.</creatorcontrib><creatorcontrib>Gleghorn, Alice</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of substance use</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wolfe, Ellen L.</au><au>Guydish, Joseph R.</au><au>Santos, Ann</au><au>Delucchi, Kevin L.</au><au>Gleghorn, Alice</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug treatment utilization before, during and after pregnancy</atitle><jtitle>Journal of substance use</jtitle><addtitle>J Subst Use</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>12</volume><issue>1</issue><spage>27</spage><epage>38</epage><pages>27-38</pages><issn>1465-9891</issn><eissn>1475-9942</eissn><abstract>This study retrospectively explored drug treatment utilization before, during and after pregnancy for all identified substance-using women delivering at a county hospital over a 4-year period (n = 431). Drug treatment data were linked to hospital data to analyse treatment utilization. Fifty-three per cent received treatment the year before, during, or within the year after delivery, with a significantly higher proportion receiving treatment during and after pregnancy. There were significant increases in methadone and residential treatment services during pregnancy. Women spent significantly more time in treatment after delivery compared with before or during pregnancy. However, 47% of these women did not receive drug treatment. These findings support current literature suggesting that pregnancy presents an opportunity to engage women in treatment. However, there is a need to decrease the institutional, legal, and funding barriers that exist between health care and drug treatment providers. Utilizing available data to track perinatal substance use and treatment utilization are important to plan for adequate availability of treatment services for this population.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>22719224</pmid><doi>10.1080/14659890600823826</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1465-9891 |
| ispartof | Journal of substance use, 2007-01, Vol.12 (1), p.27-38 |
| issn | 1465-9891 1475-9942 |
| language | eng |
| recordid | cdi_crossref_primary_10_1080_14659890600823826 |
| source | Applied Social Sciences Index & Abstracts (ASSIA); Taylor & Francis; Taylor & Francis Medical Library - CRKN |
| subjects | Drug replacement therapy drug treatment Perinatal period Pregnancy Residential treatment Substance abuse Substance use Women |
| title | Drug treatment utilization before, during and after pregnancy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T14%3A20%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug%20treatment%20utilization%20before,%20during%20and%20after%20pregnancy&rft.jtitle=Journal%20of%20substance%20use&rft.au=Wolfe,%20Ellen%20L.&rft.date=2007-01-01&rft.volume=12&rft.issue=1&rft.spage=27&rft.epage=38&rft.pages=27-38&rft.issn=1465-9891&rft.eissn=1475-9942&rft_id=info:doi/10.1080/14659890600823826&rft_dat=%3Cproquest_cross%3E57219156%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835551080&rft_id=info:pmid/22719224&rfr_iscdi=true |